Use of transdermal melatonin delivery to improve sleep maintenance during daytime

Clinical Pharmacology and Therapeutics

Volumn 86, Issue 4, 2009, Pages 378-382

  Aeschbach, D ^a,b   Lockyer, B J ^a   Dijk, D J ^c   Lockley, S W ^a,b   Nuwayser, E S ^d   Nichols, L D ^d   Czeisler, C A ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF SURREY   (United Kingdom)

^d Biotek   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN; PLACEBO;

ADULT; ALERTNESS; ARTICLE; ATTENTION; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORE TEMPERATURE; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; FEMALE; HUMAN; MALE; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REM SLEEP; SLEEP; SLEEP STAGE; SLEEP TIME; SLEEP WAKING CYCLE; SLOW WAVE SLEEP; TIME TO MAXIMUM PLASMA CONCENTRATION; TRANSDERMAL PATCH;

ADMINISTRATION, CUTANEOUS; ADULT; BODY TEMPERATURE; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CIRCADIAN RHYTHM; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; FEMALE; HALF-LIFE; HUMANS; MALE; MELATONIN; SEX FACTORS; SLEEP; SLEEP DISORDERS, CIRCADIAN RHYTHM;

EID: 70349440961     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2009.109     Document Type: Article

References (30)

1. US Congress & Office of Technology Assessment. Biological Rhythms: Implications for the Worker. (US Government Printing Office, Washington, DC, 1991).
2. Akerstedt, T. Shift work and disturbed sleep/wakefulness. Sleep Med. Rev. 2, 117-128 (1998).
3. Rajaratnam, S.M. & Arendt, J. Health in a 24-h society. Lancet 358, 999-1005 (2001).
4. Tzischinsky, O. & Lavie, P. Melatonin possesses time-dependent hypnotic effects. Sleep 17, 638-645 (1994).
5. Dollins, A.B., Zhdanova, I.V., Wurtman, R.J., Lynch, H.J. & Deng, M.H. Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. Proc. Natl. Acad. Sci. U.S.A. 91, 1824-1828 (1994).
6. Hughes, R.J. & Badia, P. Sleep-promoting and hypothermic effects of daytime melatonin administration in humans. Sleep 20, 124-131 (1997).
7. Matsumoto, M. The hypnotic effects of melatonin treatment on diurnal sleep in humans. Psychiatry Clin. Neurosci. 53, 243-245 (1999).
8. Sharkey, K.M., Fogg, L.F. & Eastman, C.I. Effects of melatonin administration on daytime sleep after simulated night shift work. J. Sleep. Res. 10, 181-192 (2001).
9. Rajaratnam, S.M., Middleton, B., Stone, B.M., Arendt, J. & Dijk, D.J. Melatonin advances the circadian timing of EEG sleep and directly facilitates sleep without altering its duration in extended sleep opportunities in humans. J. Physiol. (Lond.) 561, 339-351 (2004).
10. Wyatt, J.K., Dijk, D.J., Ritz-De Cecco, A., Ronda, J.M. & Czeisler, C.A. Sleep facilitating effect of exogenous melatonin in healthy young men and women is circadian-phase dependent. Sleep 29, 609-618 (2006).
11. Dubocovich, M.L. Melatonin receptors: role on sleep and circadian rhythm regulation. Sleep Med. (8 suppl. 3), 34-42 (2007).
12. Lee, B.J., Parrott, K.A., Ayres, J.W. & Sack, R.L. Preliminary evaluation of transdermal delivery of melatonin in human subjects. Res. Commun. Mol. Pathol. Pharmacol. 85, 337-346 (1994).
13. Garfinkel, D., Laudon, M., Nof, D. & Zisapel, N. Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet 346, 541-544 (1995).
14. Bénès, L. et al. Transmucosal, oral controlled-release, and transdermal drug administration in human subjects: a crossover study with melatonin. J. Pharm. Sci. 86, 1115-1119 (1997).
15. Priano, L. et al. Solid lipid nanoparticles incorporating melatonin as new model for sustained oral and transdermal delivery systems. J. Nanosci. Nanotechnol. 7, 3596-3601 (2007).
16. Fourtillan, J.B., Brisson, A.M., Fourtillan, M., Ingrand, I., Decourt, J.P. & Girault, J. Melatonin secretion occurs at a constant rate in both young and older men and women. Am. J. Physiol. Endocrinol. Metab. 280, E11-E22 (2001).
17. Jacobi, U., Gautier, J., Sterry, W. & Lademann, J. Gender-related differences in the physiology of the stratum corneum. Dermatology (Basel) 211, 312-317 (2005).
18. Cajochen, C., Kräuchi, K. & Wirz-Justice, A. Role of melatonin in the regulation of human circadian rhythms and sleep. J. Neuroendocrinol. 15, 432-437 (2003).
19. Monk, T.H. What can the chronobiologist do to help the shift worker? J. Biol. Rhythms 15, 86-94 (2000).
20. Santhi, N., Aeschbach, D., Horowitz, T.S. & Czeisler, C.A. The impact of sleep timing and bright light exposure on attentional impairment during night work. J. Biol. Rhythms 23, 341-352 (2008).
21. Duffy, J.F., Dijk, D.J., Klerman, E.B. & Czeisler, C.A. Later endogenous circadian temperature nadir relative to an earlier wake time in older people. Am. J. Physiol. 275, R1478-R1487 (1998).
22. Dijk, D.J. et al. Melatonin effect on daytime sleep in men: suppression of EEG low frequency activity and enhancement of spindle frequency activity. Neurosci. Lett. 201, 13-16 (1995).
23. Borbély, A.A., Mattmann, P., Loepfe, M., Strauch, I. & Lehmann, D. Effect of benzodiazepine hypnotics on all-night sleep EEG spectra. Hum. Neurobiol. 4, 189-194 (1985).
24. Landolt, H.-P. & Gillin, J.C. GABAA1a receptors: involvement in sleep regulation and potential of selective agonists in the treatment of insomnia. CNS Drugs 13, 185-199 (2000).
25. Wan, Q. et al. Differential modulation of GABAA receptor function by Mel1a and Mel1b receptors. Nat. Neurosci. 2, 401-403 (1999).
26. Nave, R., Herer, P., Haimov, I., Shlitner, A. & Lavie, P. Hypnotic and hypothermic effects of melatonin on daytime sleep in humans: lack of antagonism by flumazenil. Neurosci. Lett. 214, 123-126 (1996).
27. Dijk, D.J., Shanahan, T.L., Duffy, J.F., Ronda, J.M. & Czeisler, C.A. Variation of electroencephalographic activity during non-rapid eye movement and rapid eye movement sleep with phase of circadian melatonin rhythm in humans. J. Physiol. (Lond.) 505, 851-858 (1997).
28. Aeschbach, D., Dijk, D.J. & Borbély, A.A. Dynamics of EEG spindle frequency activity during extended sleep in humans: relationship to slow-wave activity and time of day. Brain Res. 748, 131-136 (1997).
29. Knoblauch, V., Martens, W., Wirz-Justice, A., Kräuchi, K. & Cajochen, C. Regional differences in the circadian modulation of human sleep spindle characteristics. Eur. J. Neurosci. 18, 155-163 (2003).
30. Rechtschaffen, A. & Kales, A. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. (US Government Printing Office, Washington, DC, 1968).